Meet The Team
The Founders
Anath Shalev, MD
Founder & Chief Scientific Officer
Professor of Medicine
Director, Comprehensive Diabetes Center
Nancy R. and Eugene C. Gwaltney Family Endowed Chair in Juvenile Diabetes Research
University of Alabama at Birmingham
T. Michael Goodrich, II, JD
President and Executive Board Chair
Manager
First Avenue Ventures Life Science, LLC
Birmingham, Alabama
The Scientific Advisory Board
David M. Harlan, MD
Chair, Scientific Advisory Board
William and Doris Krupp Professor of Medicine
Director, UMass Diabetes Center of Excellence
Umass Memorial Health
Umass Chan Medical School
Alan Moses, MD
Member, Scientific Advisory Board
Consultant
Senior Vice President and Chief Medical Officer of Joslin Diabetes Center (-2004)
Senior Vice President and Global Chief Medical Officer of Novo Nordisk (-2018)
C. Ronald Kahn, MD
Member, Scientific Advisory Board
Mary K. Iacocca Professor of Medicine, Harvard Medical School
Chief Academic Officer, Joslin Diabetes Center
The Development Team
G. Alexander Fleming, MD
Strategic Regulatory & Clinical Development Expert
Brian Oscherwitz, MBA, PMP
Operational Oversight
Thomas Seoh, JD
Commercialization &
Business Strategy Expert
Jo Van Betsbrugge, PhD
Chemistry, Manufacturing & Controls (CMC)
Dave Edwards, PhD
Pre-Clinical Testing
Michael B. Zemel, PhD
Translational, Clinical & Regulatory Expert
Kinexium’s Drs. Fleming, Oscherwitz, Seoh, Betsbrugge, Edwards, and Zemel have decades of experience helping guide life science companies in the diabetes and metabolism field in the design and implementation of FDA regulatory, manufacturing, nonclinical and clinical drug development and business efforts, and are now working with TIXiMED.